Lowczak, A.; Kolasinska-Cwikla, A.; Osowiecka, K.; Glinka, L.; Palucki, J.; Rzepko, R.; Doboszynska, A.; Cwikla, J.B.
Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I–IV Stage. Medicina 2021, 57, 118.
https://doi.org/10.3390/medicina57020118
AMA Style
Lowczak A, Kolasinska-Cwikla A, Osowiecka K, Glinka L, Palucki J, Rzepko R, Doboszynska A, Cwikla JB.
Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I–IV Stage. Medicina. 2021; 57(2):118.
https://doi.org/10.3390/medicina57020118
Chicago/Turabian Style
Lowczak, Anna, Agnieszka Kolasinska-Cwikla, Karolina Osowiecka, Lidia Glinka, Jakub Palucki, Robert Rzepko, Anna Doboszynska, and Jaroslaw B. Cwikla.
2021. "Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I–IV Stage" Medicina 57, no. 2: 118.
https://doi.org/10.3390/medicina57020118
APA Style
Lowczak, A., Kolasinska-Cwikla, A., Osowiecka, K., Glinka, L., Palucki, J., Rzepko, R., Doboszynska, A., & Cwikla, J. B.
(2021). Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I–IV Stage. Medicina, 57(2), 118.
https://doi.org/10.3390/medicina57020118